医学事务声誉（美国）－前列腺癌

根据这项针对 100 名美国肿瘤学家的最新调查，一些主要品牌的前列腺癌医疗事务团队的表现在几个关键领域还有待提高。该报告揭示了医生认为哪些方面做得好、他们希望哪些方面做得更好以及他们不满意的原因。了解医疗事务如何满足治疗多灶性前列腺癌的医生的高期望。比较各领先公司的医疗事务团队在前列腺癌治疗的当前表现。

报告内容

• 医师与医疗事务团队的互动频率是多少？这种频率是增加还是减少？
• 医师目前如何使用医学事务团队提供的服务？
• 医疗事务支援的哪些方面对医师来说最重要，他们对所提供的支援有多满意？
• 医师和医疗事务团队之间希望进行哪种类型的互动？互动频率如何？
• 医疗事务团队满足医师需求的程度如何？
• 医疗事务团队针对某品牌所设定的目标是否表现不佳或超乎预期？
• 未来如何改善医学事务服务以更满足医师的需求？
• 竞争对手的医疗事务团队在哪些方面最薄弱，哪些方面最强？

According to this latest survey of 100 US oncologists, the performance of prostate cancer medical affairs teams for some high profile brands still has a way to go in some key areas. Find out what physicians think is done well; what they want to see more of; and why some are dissatisfied. This report reveals how medical affairs can better meet the high expectations of physicians treating multiple prostate cancer. It compares the current performance of medical affairs teams for leading treatments for prostate cancer from various companies.

Key Questions Answered:

• 1. How frequently do physicians interact with Medical Affairs teams, and is the frequency of this interaction increasing or decreasing?
• 2. In what ways do physicians currently use the services provided by Medical Affairs teams
• 3. What aspects of Medical Affairs support are most important to physicians and how satisfied are they with the support provided?
• 4. What are the preferred mediums for interactions between physicians and Medical Affairs teams and what is the preferred frequency of these interactions?
• 5. How successful are Medical Affairs teams at meeting physician needs?
• 6. Are Medical Affairs teams falling short or exceeding goals with any particular brands?
• 7. How can Medical Affairs services be improved to better meet the needs of physicians in the future?
• 8. In what areas are your competitors' Medical Affairs teams weakest and strongest?

Methodology

FirstView reports are developed from quantitative surveys conducted with physicians selected through LiMATM, the world's largest physician directory, containing over 3 million vetted and verified physicians. Each physician is carefully chosen based on strict screening criteria to ensure the insights gathered are both relevant and reliable, reflecting the true sentiments and experiences of leading medical professionals. The findings are presented in a series of easy-to-interpret charts, enabling you to quickly grasp and analyze the data. By leveraging the vast reach and precision of LiMATM, FirstView Reports provide unparalleled, data-driven insights to guide your strategic planning and help you stay ahead in a fast-evolving healthcare landscape.

What makes our reports different?

FirstWord Reports, a trusted industry leader with an exclusive focus on the pharmaceutical sector, delivers in-depth, actionable insights for biopharma professionals and decision-makers. Our deep industry knowledge enables us to provide relevant and valuable insights that help you identify emerging trends and navigate complex challenges effectively. Backed by extensive research and independent, impartial insights from leading experts and KOLs, our reports deliver the accuracy and reliability you need. With exclusive access to interviews and data unavailable elsewhere, along with ongoing market monitoring, we give you a comprehensive view of market dynamics. Covering over 40 dynamic disease areas and providing physician intelligence, including KOL insights and quantitative physician surveys, as well as industry expert views on issues in medical affairs, digital health, sales & marketing, market access, and other areas, our reports empower you to make smarter, data-driven decisions and maintain a competitive edge in a fast-moving industry.